FindTrial
Sign In

Study of the safety and efficacy of transvaginal surgical treatment following uterine artery embolisation (UAE) combined with local methotrexate for Cesarean scar pregnancy

Study of mangement of Cesarean scar pregnancy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001641
Enrollment
Unknown
Registered
2011-10-27
Start date
2007-06-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean scar pregnancy

Interventions

1:curettage following UAE combined with local MTX
2:hysteroscopic remove following UAE combined with local MTX

Sponsors

Women's Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. a sonographic diagnosis of unruptured CSP in our hospital; 2. stable hemodynamics; 3. no prior treatment; 4. bilateral and successful UAE; 5. patient convient to follow-up in our hospital.

Exclusion criteria

Exclusion criteria: 1. CSP>12 Weeks, gestation with fetal heart beat; 2. contraindications to MTX, UAE, curettage, and hysteroscopy.

Design outcomes

Primary

MeasureTime frame
success rate;—

Countries

China

Contacts

Public ContactChen Zhengyun
czy10502@sina.com+86 13805727504

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026